Cogent Biosciences, Inc. (COGT)
USD 7.64
(-6.72%)
USD 7.64
(-6.72%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -153.62 Million | -118.63 Million | -58.76 Million | -35.85 Million | -41.51 Million | -32.48 Million |
| Net Income | -192.41 Million | -140.24 Million | -72.27 Million | -74.8 Million | -31.83 Million | -34.53 Million |
| Depreciation & Amortization | 3.58 Million | 5.87 Million | 147 Thousand | 720 Thousand | 1.29 Million | 1.32 Million |
| Deferred income taxes | -4.81 Million | - | - | -7.49 Million | - | -236 Thousand |
| Stock-based compensation | 30.62 Million | 18.36 Million | 11.68 Million | 6.01 Million | 3.24 Million | 3.08 Million |
| Change in working capital | 11.44 Million | 751 Thousand | 2.02 Million | -5.31 Million | -14.08 Million | -2.15 Million |
| Other non-cash items | -2.05 Million | -3.39 Million | -343 Thousand | 45.03 Million | -131 Thousand | 23 Thousand |
| Investing Cash Flow | -97.82 Million | -124.71 Million | -1.71 Million | 8.42 Million | 23.15 Million | -10.53 Million |
| Investments in PPE | -2.79 Million | -6.86 Million | -1.71 Million | - | -33 Thousand | -549 Thousand |
| Acquisitions | 95.02 Thousand | 117.85 Thousand | - | 8.42 Million | 204 Thousand | - |
| Investment purchases | -348.8 Million | -177.85 Million | - | - | -204 Thousand | -47.68 Million |
| Sales/Maturities of investments | 253.77 Million | 60 Million | - | - | 22.98 Million | 37.7 Million |
| Other Investing Activities | -95.02 Thousand | -117.85 Thousand | - | 8420.00 | 204 Thousand | - |
| Financing Cash Flow | 163.53 Million | 163.55 Million | 37.97 Million | 232.19 Million | 108 Thousand | 70.34 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 163.53 Million | 163.55 Million | 38 Million | 132.72 Million | 108 Thousand | 71.79 Million |
| Other Financing Activities | 163.53 Thousand | 163.55 Thousand | -30 Thousand | 99.46 Million | 108.00 | -1.44 Million |
| Accounts receivables | - | - | - | 2 Million | -332 Thousand | -838 Thousand |
| Accounts payables | 4.81 Million | 2.35 Million | 2.75 Million | -2.45 Million | 1.66 Million | 367 Thousand |
| Inventory | - | - | - | -3.55 Million | 1.21 Million | 2.21 Million |
| Other working capital | -4.81 Million | -1.6 Million | -731 Thousand | -1.31 Million | -16.63 Million | -3.89 Million |
| Cash at beginning of period | 141.14 Million | 220.93 Million | 243.44 Million | 38.67 Million | 56.92 Million | 29.6 Million |
| Cash at end of period | 53.22 Million | 141.14 Million | 220.93 Million | 243.44 Million | 38.67 Million | 56.92 Million |
| Capital Expenditure | -2.79 Million | -6.86 Million | -1.71 Million | - | -33 Thousand | -549 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -87.91 Million | -79.79 Million | -22.5 Million | 204.76 Million | -18.24 Million | 27.32 Million |
| Free Cash Flow | -156.42 Million | -125.5 Million | -60.48 Million | -35.85 Million | -41.54 Million | -33.03 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -58.95 Million | -58.34 Million | -192.41 Million | -54.36 Million | -55.38 Million | -44.07 Million |
| Depreciation & Amortization | 1.08 Million | 1.06 Million | 3.58 Million | 794 Thousand | 855 Thousand | 1.21 Million |
| Deferred income taxes | - | - | -4.81 Million | 7.76 Million | -7.76 Million | - |
| Stock-based compensation | 10.01 Million | 9.39 Million | 30.62 Million | 8.85 Million | 8.75 Million | 7.16 Million |
| Change in working capital | 2.57 Million | -3.24 Million | 11.44 Million | 4.94 Million | 6.89 Million | 4.36 Million |
| Other non-cash items | 21.34 Million | 5.21 Million | -2.05 Million | -4.29 Million | 8.66 Million | -737 Thousand |
| Investing Cash Flow | -84.62 Million | 1.04 Million | -97.82 Million | 10.48 Million | -90.53 Million | -77.66 Million |
| Investments in PPE | -148 Thousand | -70 Thousand | -2.79 Million | -315 Thousand | -121 Thousand | -1.25 Million |
| Acquisitions | - | - | 95.02 Thousand | -10.8 Thousand | 90.41 Thousand | 76.4 Thousand |
| Investment purchases | -150.39 Million | -73.01 Million | -348.8 Million | -50.91 Million | -112.47 Million | -126.4 Million |
| Sales/Maturities of investments | 65.92 Million | 74.12 Million | 253.77 Million | 61.71 Million | 22.05 Million | 50 Million |
| Other Investing Activities | -84.47 Million | 1.11 Million | -95.02 Thousand | 10.8 Thousand | -90.41 Thousand | -76.4 Thousand |
| Financing Cash Flow | -256 Thousand | 214.05 Million | 163.53 Million | - | 1 Million | 162.09 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -256 Thousand | 213.7 Million | 163.53 Million | -1.58 Million | 1 Million | 162.09 Million |
| Other Financing Activities | -256 Thousand | 356 Thousand | 163.53 Thousand | 1.42 Million | 1 Million | 162.09 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -6.59 Million | 4.91 Million | 4.81 Million | 787 Thousand | 2.7 Million | 2.98 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 9.16 Million | -8.15 Million | -4.81 Million | 4.15 Million | 4.18 Million | 1.37 Million |
| Cash at beginning of period | 215.8 Million | 53.22 Million | 141.14 Million | 86.81 Million | 214.31 Million | 161.95 Million |
| Cash at end of period | 88.21 Million | 215.8 Million | 53.22 Million | 53.22 Million | 86.81 Million | 214.31 Million |
| Capital Expenditure | -148 Thousand | -70 Thousand | -2.79 Million | -315 Thousand | -121 Thousand | -1.25 Million |
| Effect of forex changes on cash | - | - | - | -127.37 Million | 127.37 Million | - |
| Net cash flow / Change in cash | -127.58 Million | 162.57 Million | -87.91 Million | -33.58 Million | -127.5 Million | 52.36 Million |
| Free Cash Flow | -42.84 Million | -52.59 Million | -156.42 Million | -44.38 Million | -38.09 Million | -33.32 Million |
9914
TGEN
9926
BNPQY
0JZ8
003495